Renalytix Ai Stock Performance
| RNLX Stock | USD 0.16 0.01 6.67% |
The company holds a Beta of 0.24, which implies not very significant fluctuations relative to the market. As returns on the market increase, Renalytix's returns are expected to increase less than the market. However, during the bear market, the loss of holding Renalytix is expected to be smaller as well. At this point, Renalytix AI has a negative expected return of -0.87%. Please make sure to check Renalytix's treynor ratio, accumulation distribution, as well as the relationship between the Accumulation Distribution and price action indicator , to decide if Renalytix AI performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Renalytix AI has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
1 | Renalytix AI Eyes Growth with 10M Fundraise and Restructuring - TipRanks | 09/30/2024 |
2 | Acquisition by Icahn School Of Medicine At Mount Sinai of 13366750 shares of Renalytix at 0.116 subject to Rule 16b-3 | 11/01/2024 |
3 | Renalytix plc Reports Financial Results for First Quarter of Fis - GuruFocus.com | 11/20/2024 |
| Begin Period Cash Flow | 24.7 M |
Renalytix |
Renalytix Relative Risk vs. Return Landscape
If you would invest 32.00 in Renalytix AI on August 28, 2024 and sell it today you would lose (16.00) from holding Renalytix AI or give up 50.0% of portfolio value over 90 days. Renalytix AI is currently does not generate positive expected returns and assumes 6.5442% risk (volatility on return distribution) over the 90 days horizon. In different words, 58% of stocks are less volatile than Renalytix, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Renalytix Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Renalytix's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Renalytix AI, and traders can use it to determine the average amount a Renalytix's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1332
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | RNLX |
Estimated Market Risk
| 6.54 actual daily | 58 58% of assets are less volatile |
Expected Return
| -0.87 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Renalytix is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Renalytix by adding Renalytix to a well-diversified portfolio.
Renalytix Fundamentals Growth
Renalytix Stock prices reflect investors' perceptions of the future prospects and financial health of Renalytix, and Renalytix fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Renalytix Stock performance.
| Return On Equity | -10.73 | ||||
| Return On Asset | -0.94 | ||||
| Operating Margin | (9.43) % | ||||
| Current Valuation | 39.88 M | ||||
| Shares Outstanding | 82.96 M | ||||
| Price To Book | 18.77 X | ||||
| Price To Sales | 9.85 X | ||||
| Revenue | 2.29 M | ||||
| Gross Profit | 720 K | ||||
| EBITDA | (28.52 M) | ||||
| Net Income | (33.46 M) | ||||
| Cash And Equivalents | 32.36 M | ||||
| Cash Per Share | 0.89 X | ||||
| Total Debt | 8.54 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 2.48 X | ||||
| Book Value Per Share | (0.05) X | ||||
| Cash Flow From Operations | (30.11 M) | ||||
| Earnings Per Share | (0.62) X | ||||
| Market Capitalization | 22.55 M | ||||
| Total Asset | 7.97 M | ||||
| Retained Earnings | (211.78 M) | ||||
| Working Capital | 12.2 M | ||||
About Renalytix Performance
Evaluating Renalytix's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Renalytix has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Renalytix has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 111.54 | 105.96 | |
| Return On Tangible Assets | (4.20) | (4.41) | |
| Return On Capital Employed | 8.40 | 7.74 | |
| Return On Assets | (4.20) | (4.41) | |
| Return On Equity | 4.26 | 4.05 |
Things to note about Renalytix AI performance evaluation
Checking the ongoing alerts about Renalytix for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Renalytix AI help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Renalytix AI generated a negative expected return over the last 90 days | |
| Renalytix AI has high historical volatility and very poor performance | |
| Renalytix AI has some characteristics of a very speculative penny stock | |
| Renalytix AI has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 2.29 M. Net Loss for the year was (33.46 M) with profit before overhead, payroll, taxes, and interest of 720 K. | |
| Renalytix AI currently holds about 32.36 M in cash with (30.11 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.89, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Renalytix AI has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Renalytix plc Reports Financial Results for First Quarter of Fis - GuruFocus.com |
- Analyzing Renalytix's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Renalytix's stock is overvalued or undervalued compared to its peers.
- Examining Renalytix's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Renalytix's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Renalytix's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Renalytix's stock. These opinions can provide insight into Renalytix's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Renalytix Stock Analysis
When running Renalytix's price analysis, check to measure Renalytix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Renalytix is operating at the current time. Most of Renalytix's value examination focuses on studying past and present price action to predict the probability of Renalytix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Renalytix's price. Additionally, you may evaluate how the addition of Renalytix to your portfolios can decrease your overall portfolio volatility.